‘It made us look bad’: Pharma CEOs clash over Allergan patent move
November 30, 2017 at 19:11 PM EST
Allergan Chief Executive Brent Saunders stood behind the company’s controversial deal with an American Indian tribe on Thursday, despite an investor backlash and a judge ruling against it last month.